Early Trading Has AIM ImmunoTech (AIM) Moving for June 22

Equities Staff  |

Shares of AIM ImmunoTech Inc (NYSE:AIM) are on the move in pre-market trading for June 22.

Ahead of the market's open, AIM ImmunoTech stock has risen 15.81% from the previous session’s close.

AIM ImmunoTech rose $0.0017 in the last session and looks to continue today.

For technical charts, analysis, and more on AIM ImmunoTech visit the company profile.

Pre-market prices and movements as of 08:04:35 est.

About AIM ImmunoTech Inc

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

To get more information on AIM ImmunoTech Inc and to follow the company's latest updates, you can visit the company's profile page here: AIM ImmunoTech Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content